As part of the weekly research here at The Acquirer’s Multiple we’re always interested in investing gurus who hold the same stocks that appear in our Acquirer’s Multiple Stock Screeners, based on their latest 13F’s. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and Howard Marks.
While doing this research we’ve also uncovered a number of common stocks that investing gurus have recently bought, or continuing to hold in their portfolios, according to their latest 13f’s. So we’re now providing a new weekly feature article called ‘One Stock Superinvestors Are Buying’. This week we’ll take a look at:
Organon & Co (NYSE: OGN)
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women’s health, biosimilars, and established brands. Its two operating segments are the Organon Products segment and the Merck Retained Products segment. It operates in the United States, China, Japan, Korea, and countries in Europe.
A quick look at the price chart below for Organon & Co shows us that the stock is up 10% in the past twelve months.
(Source: Morningstar)
Superinvestors who recently bought, or continue to hold Organon & Co stock in their portfolios include:
(Shares)
Warren Buffett – 1,550,481
Chuck Royce – 546,803
Cliff Asness – 491,980
Israel Englander – 418,815
Jeremy Grantham – 315,462
Joel Greenblatt – 123,714
Charles Brandes – 115,984
Ken Grifin – 53,560
Mario Gabelli – 34,800
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple:
